Skip to main content
Amish Raval, MD, Cardiology, Madison, WI

Amish Raval MD

Heart Failure & Transplantation, Interventional Cardiology, Peripheral Endovascular Interventional Cardiology


Assistant Professor, Medicine, University of Wisconsin Medical School

Join to View Full Profile
  • 600 Highland aveMadison, WI 53792

  • Phone+1 608-263-1530

Dr. Raval is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Washington Hospital Center
    Washington Hospital CenterFellowship, Endovascular and Structural Heart Interventions, 2003 - 2005
  • National Heart Lung and Blood Institute
    National Heart Lung and Blood InstitutePost-Doctoral Fellowship, 2003 - 2005
  • MedStar Health Georgetown University
    MedStar Health Georgetown UniversityFellowship, Interventional Cardiology, 2002 - 2003
  • Other
    OtherClass of 1996
  • University of Western Ontario
    University of Western OntarioClass of 1996
  • University of Western Ontario
    University of Western OntarioUndergraduate studies, Mathematics and Statistical Sciences, 1990 - 1992
  • University of Western Ontario
    University of Western OntarioBachelor's, Mathematics and Statistical Sciences, 1990 - 1992

Certifications & Licensure

  • WI State Medical License
    WI State Medical License 2005 - 2025
  • DC State Medical License
    DC State Medical License 2002 - 2006
  • Cardiovascular Disease
    American Board of Internal Medicine Cardiovascular Disease
  • Interventional Cardiology
    American Board of Internal Medicine Interventional Cardiology

Publications & Presentations

PubMed

Press Mentions

  • BioCardia Initiates Patient Enrollment at University of Wisconsin at Madison for Ongoing CardiAMP HF II Pivotal Study
    BioCardia Initiates Patient Enrollment at University of Wisconsin at Madison for Ongoing CardiAMP HF II Pivotal StudyMay 6th, 2025
  • In Heart Failure, Cellular Therapy Is Active
    In Heart Failure, Cellular Therapy Is ActiveApril 21st, 2025
  • Biocardia Phase 3 CardiAMP-HF Trial of Novel Cardiac Cell Therapy for Ischemic Heart Failure Shows Increased Survival, Decreased Cardiac Events, and Improved Quality of Life at Two Years
    Biocardia Phase 3 CardiAMP-HF Trial of Novel Cardiac Cell Therapy for Ischemic Heart Failure Shows Increased Survival, Decreased Cardiac Events, and Improved Quality of Life at Two YearsMarch 31st, 2025
  • Join now to see all

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: